IUSTI Helsinki

Twitter account for the 31st Congress of IUSTI Europe

[IUSTI Helsinki @IustiHelsinki]

IUSTI Helsinki 2017 hands over to #IUSTI2018 🇮🇪Abstracts & registration are open. Please follow @iusti2018 to keep up to date.

[EU One Health @EU_Health]

Last places available: EU conference on testing and care for HIV, Hepatitis, TB & STIs, on 19/09. Register here: https://t.co/fDiUtFFw3V

[SpeeDx @speedx]

A great conference filled with fantastic talks and presentations #IUSTI2017. Awesome to be involved in halting the spread of #AMR

[IUSTI Helsinki @IustiHelsinki]

Thanks to the folk helping with #IUSTI2017 twitter feed @TeoWinterAndy @milleogbasillen & @gmacscotland for analysis from afar. Safe travels

[IUSTI Helsinki @IustiHelsinki]

Our wonderful conference chair joins twitter!! Everyone is so grateful for such hard work #IUSTI2017 https://t.co/JliyJZ2wau

[Eija Hiltunen-Back @BackEija]

#IUSTI2017 over, lovely sunset in Helsinki

[IUSTI Helsinki @IustiHelsinki]

#IUSTI2017 closing after a successful meeting looking forward to #IUSTI2018 in Dublin https://t.co/Cx83GNvyPM 27-30 June 2018

[IUSTI Helsinki @IustiHelsinki]

Closing ceremony for #IUSTI2017: delegates relieved to hear prevalence of Ct/GC was 0%

[IUSTI Helsinki @IustiHelsinki]

Patel - HSV2 was likely a separate zoonotic infection from chimpanzees ca.1 million years ago https://t.co/ir2Xo01GGw #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

Patel discussing new data for HSV on tenofovir, pritelivir, vaccines, global variations in glycoprotein G. #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

Messagewall has been great at getting delegates involved and summarises tweets and questions #IUSTI2017 https://t.co/jz0GUhNJTs

[iwantPrEPnow @iwantPrEPnow]

We'll just leave this here: from Prof Battegay on #TasP and #PrEP at #IUSTI2017. @EACSociety @ECDC_HIVAIDS @DYNAMIX_PrEP

[IUSTI Helsinki @IustiHelsinki]

DrasExp the Barcelona @56deanstreet using GeneXpert started Nov 2016 271 users/mth 45% non-EU 17% never HIV tested 20% RPR+ve #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

Unhappy figures for M.gen #AntimicrobialResistance from @PHE_uk presented at #IUSTI2017 https://t.co/ffgnQ5tj8U @STI_BMJ

[IUSTI Helsinki @IustiHelsinki]

More nails in the azithromycin stat dose coffin. Whiley outlining GyrA 91-targeted ciprofloxacin Rx for #gonorrhoea GRAND study #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

Big turnout for the @speedx symposium on M.gen 'closer to becoming first bacterial untreatable STI' - Jensen and #gonorrhoea #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

Less optimistic talk from Paavonen: in spite of huge evidence base for safety uptake for #HPV vaccine around 60% in Europe #IUSTI2017

[Miriam Sare @milleogbasillen]

Paavonen praising @gavi https://t.co/7WDp5Pg8Ia for tackling cervical cancer by access to #HPVvaccine in developing countries #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

New #PrEP online learning on @EACSociety website https://t.co/d45G4h14R1 aimed at Eastern Europe / Central Asia clinicians #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

Tenofovir-DP likely has specific efficacy due to high penetration into rectal tissues -Battegay #IUSTI2017

[IUSTI Helsinki @IustiHelsinki]

Sustained #PrEP efficacy and no rise in STIs in open-label continuation IPERGAY https://t.co/bGbsG0Qstr #IUSTI2017